3 months ago
BMRN
AnalystsMitchell S. KapoorMitchell S. Kapoor's Stock Forecasts
AnalystsMitchell S. Kapoor
Sectors:
Industries:
Analyst Ranking
Top 19%
#987 out of 5177 analysts
Average Return
+10.59%
Win Rate
51%30 out of 59
Risk vs Reward
Poor
Good
Mitchell S. Kapoor's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alumis IncALMS | +450.57% | $4.39 | $24.17 | 2025-08-14 - 2026-01-15 | Buy |
Tyra Biosciences IncTYRA | +147.82% | $11.71 | $29.02 | 2025-08-22 - 2026-01-15 | Buy |
Kyverna Therapeutics IncKYTX | +135.04% | $3.71 | $8.72 | 2025-08-29 - 2026-01-15 | Buy |
Alumis IncALMS | +118.54% | $11.06 | $24.17 | 2025-12-18 - 2026-01-15 | Buy |
Oruka Therapeutics IncORKA | +113.11% | $15.25 | $32.50 | 2025-08-18 - 2026-01-15 | Buy |
Mitchell S. Kapoor Analyst Color
Get additional color on Mitchell S. Kapoor's coverage of popular stocks
4 months ago
BMRN
Mitchell S. Kapoor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Avalo Therapeutics IncAVTX | 2 | Buy | $25.00 | +59.85% | Reiterates | 2 days ago |
Sarepta Therapeutics IncSRPT | 2 | Sell | $5.00 | -76.54% | Reiterates | 3 days ago |
Neurogene IncNGNE | 4 | Buy | $70.00 | +287.60% | Reiterates | 4 days ago |
Lexeo Therapeutics IncLXEO | 4 | Buy | $10.00 | +33.33% | Maintains | 4 days ago |
Alumis IncALMS | 3 | Buy | $40.00 | +65.49% | Reiterates | 8 days ago |
Evommune IncEVMN | 1 | Buy | $35.00 | +78.57% | Initiates Coverage On | 11 days ago |
Biomarin Pharmaceutical IncBMRN | 3 | Hold | $60.00 | +8.95% | Maintains | a month ago |
Halozyme Therapeutics IncHALO | 5 | Buy | $90.00 | +25.31% | Reiterates | a month ago |
Lyell Immunopharma IncLYEL | 2 | Buy | $45.00 | +96.25% | Upgrades | a month ago |
Meiragtx Holdings PLCMGTX | 1 | Buy | $20.00 | +160.08% | Initiates Coverage On | 2 months ago |
Cartesian Therapeutics IncRNAC | 1 | Buy | $30.00 | +307.61% | Maintains | 2 months ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $10.00 | +135.29% | Maintains | 2 months ago |
Intellia Therapeutics IncNTLA | 5 | Buy | $15.00 | +26.37% | Maintains | 2 months ago |
Ionis Pharmaceuticals IncIONS | 6 | Buy | $110.00 | +42.47% | Maintains | 2 months ago |
Kyverna Therapeutics IncKYTX | 2 | Buy | $20.00 | +129.36% | Maintains | 3 months ago |
Oruka Therapeutics IncORKA | 2 | Buy | $40.00 | +23.08% | Maintains | 3 months ago |
Summit Therapeutics IncSMMT | 6 | Buy | $40.00 | +131.62% | Maintains | 3 months ago |
Legend Biotech CorpLEGN | 1 | Buy | $60.00 | +171.37% | Maintains | 3 months ago |
Crispr Therapeutics AgCRSP | 1 | Buy | $80.00 | +47.57% | Reiterates | 4 months ago |
Instil Bio IncTIL | 3 | Buy | $125.00 | +1,658.09% | Reiterates | 4 months ago |
Editas Medicine IncEDIT | 2 | Buy | $5.00 | +139.23% | Reiterates | 4 months ago |
Crescent Biopharma IncCBIO | 2 | Buy | $25.00 | +100.00% | Reiterates | 5 months ago |
Tyra Biosciences IncTYRA | 1 | Buy | $30.00 | +3.38% | Reiterates | 5 months ago |
Metagenomi IncMGX | 1 | Buy | $7.00 | +314.20% | Reiterates | 5 months ago |
Zura Bio LtdZURA | 1 | Hold | $2.00 | -57.36% | Maintains | 5 months ago |
Korro Bio IncKRRO | 1 | Buy | $90.00 | +922.73% | Maintains | 5 months ago |
Boundless Bio IncBOLD | 1 | Buy | $4.00 | +220.00% | Maintains | 5 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.